Millions of People Will Soon Be Blindsided. Will You Be One of Them?

On April 20 at 7 p.m. ET, Louis Navellier and Matt McCall will reveal an event that’s about to rock the stock market and how you could use it to beat the markets by nearly 11X.

Tue, April 20 at 7:00PM ET

5 Medical Devices Stocks to Sell Now

The ratings of five Medical Devices stocks are down this week, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).

Natus Medical’s (NASDAQ:BABY) rating falls to a D (“sell”) this week, down from C (“hold”) the week prior. Natus Medical is a medical device company that develops, manufactures, and markets screening products. In Portfolio Grader’s specific subcategories of Earnings Growth and Margin Growth, BABY also gets F’s. The stock price has fallen 6.9% over the past month, worse than the 2.3% increase the Nasdaq has seen over the same period of time. For more information, get Portfolio Grader’s complete analysis of BABY stock.

Accuray (NASDAQ:ARAY) earns an F (“strong sell”) this week, moving down from last week’s grade of D (“sell”). Accuray designs, develops, and sells medical radiation systems for the treatment of tumors anywhere in the body. The stock receives F’s in Earnings Revisions, Equity, Cash Flow, and Sales Growth. Share prices fell 11.4% over the past month. For a full analysis of ARAY stock, visit Portfolio Grader.

This week, Palomar Medical Technologies’ (NASDAQ:PMTI) rating worsens to a D from the company’s C rating a week ago. Palomar Medical Technologies develops and supplies proprietary laser systems for hair removal and other cosmetic laser treatments. The stock gets F’s in Earnings Growth, Equity, and Margin Growth. For more information, get Portfolio Grader’s complete analysis of PMTI stock.

This is a rough week for Hologic Inc. (NASDAQ:HOLX). The company’s rating falls to D from the previous week’s C. Hologic develops, manufactures, and markets x-ray systems. The stock gets F’s in Earnings Growth and Margin Growth. For a full analysis of HOLX stock, visit Portfolio Grader.

Invacare (NYSE:IVC) earns an F this week, falling from last week’s grade of D. Invacare manufactures and distributes health care products to the non-acute care market on a worldwide basis. In Earnings Growth, Earnings Revisions, Earnings Surprise, and Margin Growth the stock gets F’s. To get an in-depth look at IVC, get Portfolio Grader’s complete analysis of IVC stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.

Article printed from InvestorPlace Media,

©2021 InvestorPlace Media, LLC